Sorting The Hope Versus The Hype Of Cancer Treatments
Matching the right patient to the right treatment is the essence of what we do at the Cancer Treatment Navigator (CTN). A Guardian news article captures our approach of evaluating tumors based on site as well as specificity of mutations, and identifying treatments based on individual disease and genetic profile. Several cancers such as breast cancer and prostate cancer are treatable via personalized medicine in clinics and hospitals. But most have personalized medicine available largely in investigational clinical trial protocols. The CTN team considers cancer clinical trials as viable treatment options and researches the full array of approved and experimental therapies on an individual patient basis. This often results in recommending cancer patients treatments, that might not have been considered yet by their Oncologist. Bringing a personalized scientific arm to your cancer care team helps sort the hope from the hype.